Get access to our best features
Get access to our best features
Published 1 year ago

Merck COVID-19 pill linked to virus mutations – study (NYSE:MRK)

Summary by Ground News
Lagevrio, the FDA-authorized oral COVID-19 therapy, leads to new mutations in the virus, according to a new study. The researchers in the U.S. and U.K. collaborated with those in the Francis Crick Institute, Imperial College, and the University of Liverpool.

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 33% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
34% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics